{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:53:53Z","timestamp":1792083233162,"version":"4.4.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jns.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T12:16:26Z","timestamp":1365423386000},"page":"76-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":240,"title":["Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination"],"prefix":"10.1016","volume":"333","author":[{"given":"Abdolmohamad","family":"Rostami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogoljub","family":"Ciric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jns.2013.03.002_bb0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2014the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0015","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"Steinman","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.03.002_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.20.081701.141316","article-title":"T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire","volume":"20","author":"Kuchroo","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-60327-931-4_11","article-title":"Animal models of multiple sclerosis","volume":"549","author":"Furlan","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"3,4","key":"10.1016\/j.jns.2013.03.002_bb0035","first-page":"229","article-title":"Immunology of multiple sclerosis","volume":"2","author":"Williams","year":"1994","journal-title":"Clin Neurosci"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0040","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"issue":"6179","key":"10.1016\/j.jns.2013.03.002_bb0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0008-8749(89)90117-2","article-title":"Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype","volume":"124","author":"Ando","year":"1989","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/08916939309043888","article-title":"T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes","volume":"15","author":"Voskuhl","year":"1993","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-5728(93)90195-5","article-title":"Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells","volume":"48","author":"van der Veen","year":"1993","journal-title":"J Neuroimmunol"},{"issue":"3,4","key":"10.1016\/j.jns.2013.03.002_bb0065","first-page":"225","article-title":"Influence of tobacco smoking on serum free fatty acid, triglyceride and glucose levels during physical training and post-exertional restitution","volume":"35","author":"Markiewicz","year":"1978","journal-title":"Acta Med Acad Sci Hung"},{"key":"10.1016\/j.jns.2013.03.002_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1600-065X.1995.tb00072.x","article-title":"Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"144","author":"Olsson","year":"1995","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2012.01126.x","article-title":"Mechanisms regulating regional localization of inflammation during CNS autoimmunity","volume":"248","author":"Pierson","year":"2012","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410240211","article-title":"Multiple sclerosis: involvement of interferons in lesion pathogenesis","volume":"24","author":"Traugott","year":"1988","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1084\/jem.177.2.523","article-title":"Interferon gamma inhibits interleukin 10 production by monocytes","volume":"177","author":"Chomarat","year":"1993","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-7915(97)80154-9","article-title":"Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma)","volume":"9","author":"Trinchieri","year":"1997","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.37.7.1097","article-title":"Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system","volume":"37","author":"Panitch","year":"1987","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI200112563","article-title":"Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis","volume":"108","author":"Chitnis","year":"2001","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0105","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.181.5.1755","article-title":"Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4","volume":"18","author":"Jacobson","year":"1995","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20031819","article-title":"Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis","volume":"200","author":"Bettelli","year":"2004","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0115","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.4049\/jimmunol.169.12.7104","article-title":"IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination","volume":"169","author":"Gran","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0120","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/eji.1830260735","article-title":"Interferon-gamma confers resistance to experimental allergic encephalomyelitis","volume":"26","author":"Krakowski","year":"1996","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0125","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.4049\/jimmunol.164.5.2759","article-title":"IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines","volume":"164","author":"Tran","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0130","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.4049\/jimmunol.170.4.2153","article-title":"Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system","volume":"170","author":"Zhang","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-5728(94)90069-8","article-title":"Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains","volume":"53","author":"Duong","year":"1994","journal-title":"J Neuroimmunol"},{"issue":"2,3","key":"10.1016\/j.jns.2013.03.002_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-5728(92)90042-J","article-title":"Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL\/J mouse","volume":"36","author":"Duong","year":"1992","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0145","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/eji.1830261019","article-title":"Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma","volume":"26","author":"Heremans","year":"1996","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.156.1.5","article-title":"Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)","volume":"156","author":"Ferber","year":"1996","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0155","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.4049\/jimmunol.157.8.3223","article-title":"IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis","volume":"157","author":"Willenborg","year":"1996","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0160","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.4049\/jimmunol.163.10.5278","article-title":"IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide","volume":"163","author":"Willenborg","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu Rev Immunol"},{"issue":"21","key":"10.1016\/j.jns.2013.03.002_bb0170","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","article-title":"Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming","volume":"90","author":"Seder","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.181.1.381","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12","volume":"181","author":"Leonard","year":"1995","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0180","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.4049\/jimmunol.161.12.7015","article-title":"Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline","volume":"161","author":"Bright","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0185","first-page":"171","article-title":"Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice","volume":"10","author":"Heremans","year":"1999","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0165-5728(99)00153-8","article-title":"Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing\u2013remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide","volume":"102","author":"Ichikawa","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0195","first-page":"249","article-title":"The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells","volume":"21","author":"Shevach","year":"1999","journal-title":"Springer Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI0215751","article-title":"Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12","volume":"110","author":"Becher","year":"2002","journal-title":"J Clin Invest"},{"issue":"5,6","key":"10.1016\/j.jns.2013.03.002_bb0205","first-page":"545","article-title":"Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12","volume":"17","author":"Leonard","year":"1997","journal-title":"Crit Rev Immunol"},{"issue":"1,2","key":"10.1016\/j.jns.2013.03.002_bb0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2004.07.019","article-title":"Early administration of IL-12 suppresses EAE through induction of interferon-gamma","volume":"156","author":"Gran","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"1,2","key":"10.1016\/j.jns.2013.03.002_bb0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2007.01.012","article-title":"The PD-1\/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma","volume":"185","author":"Cheng","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"1,2","key":"10.1016\/j.jns.2013.03.002_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.04.009","article-title":"Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way","volume":"176","author":"Berghmans","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0225","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1521-4141(200106)31:6<1800::AID-IMMU1800>3.0.CO;2-S","article-title":"Two-step activation of T cells, clonal expansion and subsequent Th1 cytokine production, is essential for the development of clinical autoimmune encephalomyelitis","volume":"31","author":"Jee","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(99)00249-X","article-title":"IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE)","volume":"171","author":"Constantinescu","year":"1999","journal-title":"J Neurol Sci"},{"issue":"1,2","key":"10.1016\/j.jns.2013.03.002_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-5728(03)00180-2","article-title":"Interleukin-12 induces mild experimental allergic encephalomyelitis following local central nervous system injury in the Lewis rat","volume":"140","author":"Ahmed","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1749-6632.1996.tb52684.x","article-title":"Astrocytes and microglia produce interleukin-12 p40","volume":"795","author":"Constantinescu","year":"1996","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0245","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.4049\/jimmunol.161.9.5097","article-title":"Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis","volume":"161","author":"Constantinescu","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/clim.2000.4944","article-title":"Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively","volume":"98","author":"Constantinescu","year":"2001","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.153.1.128","article-title":"Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130","volume":"53(","author":"Chua","year":"1994","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0260","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.4049\/jimmunol.155.9.4286","article-title":"Cloning and characterization of a mouse IL-12 receptor-beta component","volume":"155","author":"Chua","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.1996.tb52653.x","article-title":"Molecular biology of interleukin-12 receptors","volume":"795","author":"Gubler","year":"1996","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0270","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.4049\/jimmunol.171.9.4485","article-title":"Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis","volume":"171","author":"Zhang","year":"2003","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0275","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0280","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.molimm.2007.07.003","article-title":"IL-12\/IFN-gamma\/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis","volume":"45","author":"Xiao","year":"2008","journal-title":"Mol Immunol"},{"issue":"6924","key":"10.1016\/j.jns.2013.03.002_bb0285","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0290","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0295","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1084\/jem.20071450","article-title":"Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells","volume":"205","author":"Gerosa","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2013.03.002_bb0300","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","article-title":"Regulation of interleukin-12\/interleukin-23 production and the T-helper 17 response in humans","volume":"226","author":"Lyakh","year":"2008","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0305","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.179.5.3268","article-title":"Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis","volume":"179","author":"Fitzgerald","year":"2007","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0310","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0315","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0320","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0325","first-page":"61","article-title":"IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice","volume":"119","author":"Haak","year":"2009","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0335","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.20080159","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition","volume":"205","author":"Kroenke","year":"2008","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0340","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.0900645","article-title":"Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells","volume":"183","author":"Tigno-Aranjuez","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0345","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI25308","article-title":"Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0350","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/eji.200636662","article-title":"Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis","volume":"36","author":"Uyttenhove","year":"2006","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0355","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood.V56.6.947.947","article-title":"The nature and action of granulocyte-macrophage colony stimulating factors","volume":"56","author":"Burgess","year":"1980","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4049\/jimmunol.178.1.39","article-title":"GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis","volume":"178","author":"Ponomarev","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0365","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0370","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jlb.55.3.355","article-title":"Coordinate and noncoordinate colony stimulating factor formation by human monocytes","volume":"55","author":"Hamilton","year":"1994","journal-title":"J Leukoc Biol"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0380","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1681\/ASN.2004121107","article-title":"Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis","volume":"16","author":"Timoshanko","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0385","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1172\/JCI112512","article-title":"Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2","volume":"77","author":"Zucali","year":"1986","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0390","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI112717","article-title":"Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells","volume":"78","author":"Bagby","year":"1986","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0395","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood.V76.10.1989.1989","article-title":"Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor","volume":"76","author":"Leizer","year":"1990","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0400","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4049\/jimmunol.147.4.1238","article-title":"Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1","volume":"147","author":"Campbell","year":"1991","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0405","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(93)90026-Q","article-title":"Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells","volume":"99","author":"Filonzi","year":"1993","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0410","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1002\/j.1460-2075.1989.tb08541.x","article-title":"Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor","volume":"8","author":"Gearing","year":"1989","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0415","first-page":"111","article-title":"Myeloid haemopoietic growth factors","volume":"989","author":"Whetton","year":"1989","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0420","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V82.12.3515.3515","article-title":"Hematopoietic regulators: redundancy or subtlety?","volume":"82","author":"Metcalf","year":"1993","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0425","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0092-8674(91)90039-2","article-title":"Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors","volume":"66","author":"Kitamura","year":"1991","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0430","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0092-8674(91)90040-6","article-title":"A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF","volume":"66","author":"Tavernier","year":"1991","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0435","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0440","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.168.4.1395","article-title":"Keratinocyte growth regulation by the products of immune cells","volume":"168","author":"Hancock","year":"1988","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0445","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V89.3.863","article-title":"Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor","volume":"89","author":"Soldi","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0450","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2007.03.065","article-title":"Signal transduction pathways of GM-CSF in neural cell lines","volume":"420","author":"Choi","year":"2007","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0455","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.V73.4.1033.1033","article-title":"Nonhematopoietic tumor cells express functional GM-CSF receptors","volume":"73","author":"Baldwin","year":"1989","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jns.2013.03.002_bb0460","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1073\/pnas.85.23.9253","article-title":"Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin","volume":"85","author":"Dedhar","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6206","key":"10.1016\/j.jns.2013.03.002_bb0465","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/337471a0","article-title":"Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate","volume":"337","author":"Bussolino","year":"1989","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0470","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1172\/JCI115107","article-title":"In vitro and in vivo activation of endothelial cells by colony-stimulating factors","volume":"87","author":"Bussolino","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0475","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V91.3.1037","article-title":"Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer","volume":"91","author":"Rivas","year":"1998","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.jns.2013.03.002_bb0480","doi-asserted-by":"crossref","first-page":"42808","DOI":"10.1074\/jbc.M207840200","article-title":"Granulocyte\/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt\/Erk activation of NFkappa B and AP-1 in vivo","volume":"277","author":"Bozinovski","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0485","doi-asserted-by":"crossref","first-page":"L877","DOI":"10.1152\/ajplung.00275.2003","article-title":"Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4","volume":"286","author":"Bozinovski","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0490","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1615\/CritRevImmunol.v25.i5.50","article-title":"Functions of granulocyte-macrophage colony-stimulating factor","volume":"25","author":"Fleetwood","year":"2005","journal-title":"Crit Rev Immunol"},{"issue":"5667","key":"10.1016\/j.jns.2013.03.002_bb0495","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/274168a0","article-title":"Induction of macrophage production and proliferation by a purified colony stimulating factor","volume":"274","author":"Stanley","year":"1978","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0500","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V","article-title":"Biology and action of colony-stimulating factor-1","volume":"46","author":"Stanley","year":"1997","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0505","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7434","article-title":"Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization","volume":"5","author":"Takahashi","year":"1999","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0515","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.161.7.3639","article-title":"Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice","volume":"161","author":"Campbell","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0520","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/ar318","article-title":"Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease","volume":"3","author":"Cook","year":"2001","journal-title":"Arthritis Res"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0525","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.194.7.873","article-title":"Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis","volume":"194","author":"McQualter","year":"2001","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0530","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1681\/ASN.V132350","article-title":"The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury","volume":"13","author":"Kitching","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0535","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.4049\/jimmunol.173.10.6384","article-title":"Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism","volume":"173","author":"Cates","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0540","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2006.03.007","article-title":"Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF)","volume":"112","author":"Vlahos","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0545","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0008-8749(02)00565-8","article-title":"Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF)","volume":"219","author":"Yamashita","year":"2002","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0550","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.ATV.0000238357.60338.90","article-title":"GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice","volume":"26","author":"Ditiatkovski","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.jns.2013.03.002_bb0555","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1161\/01.CIR.99.16.2150","article-title":"Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits","volume":"99","author":"Shindo","year":"1999","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0560","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1182\/blood.V92.12.4491","article-title":"Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Armitage","year":"1998","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0565","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI25681","article-title":"GM-CSF action in the CNS decreases food intake and body weight","volume":"115","author":"Reed","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0570","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.4049\/jimmunol.179.6.3638","article-title":"Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells","volume":"179","author":"Gaudreau","year":"2007","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0575","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0580","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0585","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4049\/jimmunol.172.4.2225","article-title":"WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27","volume":"172","author":"Pflanz","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0590","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4049\/jimmunol.173.2.715","article-title":"Understanding the pro- and anti-inflammatory properties of IL-27","volume":"173","author":"Villarino","year":"2004","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0595","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.170.10.4886","article-title":"Cutting edge: role of IL-27\/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment","volume":"170","author":"Takeda","year":"2003","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0600","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0605","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0610","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0615","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.179.7.4415","article-title":"IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation","volume":"179","author":"Yoshimoto","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0620","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/intimm\/dxm139","article-title":"IL-27 inhibits the development of regulatory T cells via STAT3","volume":"20","author":"Huber","year":"2008","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0625","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.4049\/jimmunol.179.10.6421","article-title":"Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0630","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1172\/JCI33342","article-title":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice","volume":"118","author":"Guo","year":"2008","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0635","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2008.06.038","article-title":"Amelioration of delayed-type hypersensitivity responses by IL-27 administration","volume":"373","author":"Miyazaki","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0640","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.180.2.922","article-title":"IL-27 induces a Th1 immune response and susceptibility to experimental arthritis","volume":"180","author":"Cao","year":"2008","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0645","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/ard.2007.077537","article-title":"Amelioration of human lupus-like phenotypes in MRL\/lpr mice by overexpression of IL-27R{alpha} (WSX-1)","volume":"67","author":"Sugiyama","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0650","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.4049\/jimmunol.1200131","article-title":"Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27","volume":"189","author":"Young","year":"2012","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0655","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.4049\/jimmunol.0900735","article-title":"Differential effect of IL-27 on developing versus committed Th17 cells","volume":"183","author":"El-behi","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0660","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ni.1659","article-title":"Transforming growth factor-beta \u2018reprograms\u2019 the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset","volume":"9","author":"Veldhoen","year":"2008","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0665","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(\u2212) effector T cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v32.i1.10","article-title":"The unique features of Th9 cells and their products","volume":"32","author":"Tan","year":"2012","journal-title":"Crit Rev Immunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0675","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.coi.2012.02.001","article-title":"The symphony of the ninth: the development and function of Th9 cells","volume":"24","author":"Jabeen","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0680","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2011.06351.x","article-title":"From interleukin-9 to T helper 9 cells","volume":"1247","author":"Stassen","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0685","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ni.2133","article-title":"An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation","volume":"12","author":"Wilhelm","year":"2011","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0690","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2567.2010.03332.x","article-title":"Interleukin-9 as a T helper type 17 cytokine","volume":"131","author":"Nowak","year":"2010","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0695","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11481-009-9186-y","article-title":"IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity","volume":"5","author":"Li","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0700","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/eji.1830200632","article-title":"Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40\/TCGFIII (interleukin 9)","volume":"20","author":"Hultner","year":"1990","journal-title":"Eur J Immunol"},{"issue":"18","key":"10.1016\/j.jns.2013.03.002_bb0705","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.85.18.6934","article-title":"Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity","volume":"85","author":"Uyttenhove","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"10.1016\/j.jns.2013.03.002_bb0710","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0812530106","article-title":"IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0715","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","article-title":"Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells","volume":"36","author":"Elyaman","year":"2012","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0720","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20090246","article-title":"IL-9 as a mediator of Th17-driven inflammatory disease","volume":"206","author":"Nowak","year":"2009","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0725","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.4049\/jimmunol.1000986","article-title":"Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0730","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/eji.201041125","article-title":"IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system","volume":"41","author":"Li","year":"2011","journal-title":"Eur J Immunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0735","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.1200808","article-title":"IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27","volume":"189","author":"Murugaiyan","year":"2012","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0740","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1003307","article-title":"IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes","volume":"186","author":"Zhou","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0745","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI65459","article-title":"Th9 cells promote antitumor immune responses in vivo","volume":"122","author":"Lu","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0750","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"Jager","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0755","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.4049\/jimmunol.1001676","article-title":"Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site","volume":"185","author":"Tan","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0760","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0765","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0770","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0775","doi-asserted-by":"crossref","first-page":"a007021","DOI":"10.1101\/cshperspect.a007021","article-title":"Treg cells, life history, and diversity","volume":"4","author":"Benoist","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"10.1016\/j.jns.2013.03.002_bb0780","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.smim.2011.06.001","article-title":"Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells","volume":"23","author":"Kim","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0785","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0790","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0795","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-065X.2012.01130.x","article-title":"Regulatory T cells in the central nervous system","volume":"248","author":"Lowther","year":"2012","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0800","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humimm.2011.12.012","article-title":"Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function","volume":"73","author":"Geiger","year":"2012","journal-title":"Hum Immunol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb0805","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jns.2013.03.002_bb0810","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0815","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1084\/jem.178.3.909","article-title":"The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease","volume":"178","author":"Kumar","year":"1993","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0820","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0092-8674(94)90419-7","article-title":"High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice","volume":"78","author":"Lafaille","year":"1994","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jns.2013.03.002_bb0825","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1084\/jem.188.10.1883","article-title":"Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis","volume":"188","author":"Olivares-Villagomez","year":"1998","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0830","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J Immunol"},{"issue":"43","key":"10.1016\/j.jns.2013.03.002_bb0835","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1073\/pnas.0404444101","article-title":"Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7152","key":"10.1016\/j.jns.2013.03.002_bb0840","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.jns.2013.03.002_bb0845","doi-asserted-by":"crossref","first-page":"17418","DOI":"10.1073\/pnas.0507454102","article-title":"CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity","volume":"102","author":"Stephens","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0850","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/intimm\/dxh029","article-title":"IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.05.001","article-title":"Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies","volume":"23","author":"Montero","year":"2004","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0860","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1402","article-title":"Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE","volume":"12","author":"Liu","year":"2006","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0865","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0870","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","article-title":"Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system","volume":"175","author":"McGeachy","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0875","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4049\/jimmunol.179.2.958","article-title":"The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells","volume":"179","author":"O'Connor","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0880","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/glia.20046","article-title":"Astrocyte-induced regulatory T cells mitigate CNS autoimmunity","volume":"47","author":"Trajkovic","year":"2004","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0885","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0890","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients","volume":"147","author":"Feger","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0895","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2567.2008.02963.x","article-title":"Regulatory T cells fail to suppress CD4T+\u2212bet+T cells in relapsing multiple sclerosis patients","volume":"127","author":"Frisullo","year":"2009","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0900","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0905","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.4049\/jimmunol.180.9.6411","article-title":"Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression","volume":"180","author":"Venken","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0910","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0915","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J Neurosci Res"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0920","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/jnr.20852","article-title":"Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression","volume":"83","author":"Venken","year":"2006","journal-title":"J Neurosci Res"},{"issue":"1,2","key":"10.1016\/j.jns.2013.03.002_bb0925","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jneuroim.2006.09.012","article-title":"Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis","volume":"182","author":"de Andres","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"11","key":"10.1016\/j.jns.2013.03.002_bb0930","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archneur.65.11.1434","article-title":"Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells","volume":"65","author":"Korporal","year":"2008","journal-title":"Arch Neurol"},{"issue":"18","key":"10.1016\/j.jns.2013.03.002_bb0935","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.0502187102","article-title":"Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3","volume":"102","author":"Hong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jns.2013.03.002_bb0940","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0945","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ni1363","article-title":"Selection of the cutaneous intraepithelial gammadelta+T cell repertoire by a thymic stromal determinant","volume":"7","author":"Lewis","year":"2006","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.jns.2013.03.002_bb0950","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.151.9.4465","article-title":"Most gamma delta T cells develop normally in the absence of MHC class II molecules","volume":"15","author":"Bigby","year":"1993","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0955","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1073\/pnas.89.2.653","article-title":"Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice","volume":"89","author":"Correa","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0960","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/eji.1830270717","article-title":"Patterns of lymphokine secretion amongst mouse gamma delta T cell clones","volume":"27","author":"Duhindan","year":"1997","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb0965","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/eji.200838354","article-title":"A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury","volume":"38","author":"Rhodes","year":"2008","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb0970","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.immuni.2008.04.022","article-title":"Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma","volume":"29","author":"Jensen","year":"2008","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.jns.2013.03.002_bb0975","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4049\/jimmunol.1103308","article-title":"Inflammasome-derived IL-1beta regulates the production of GM-CSF by CD4(+) T cells and gammadelta T cells","volume":"188","author":"Lukens","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb0980","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.immuni.2009.06.020","article-title":"Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals","volume":"31","author":"Martin","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jns.2013.03.002_bb0985","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ni.1717","article-title":"CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets","volume":"10","author":"Ribot","year":"2009","journal-title":"Nat Immunol"},{"issue":"1,2","key":"10.1016\/j.jns.2013.03.002_bb0990","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-5728(96)00187-7","article-title":"Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody","volume":"73","author":"Kobayashi","year":"1997","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb0995","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4049\/jimmunol.173.3.1587","article-title":"Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis","volume":"173","author":"Ponomarev","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jns.2013.03.002_bb1000","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.4049\/jimmunol.174.8.4678","article-title":"Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism","volume":"174","author":"Ponomarev","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jns.2013.03.002_bb1005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/jaut.1997.0180","article-title":"Adoptively transferred EAE in gamma delta T cell-knockout mice","volume":"11","author":"Clark","year":"1998","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb1010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4049\/jimmunol.157.2.941","article-title":"A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse","volume":"157","author":"Rajan","year":"1996","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb1015","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.4049\/jimmunol.160.12.5955","article-title":"The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis","volume":"160","author":"Rajan","year":"1998","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jns.2013.03.002_bb1020","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S","article-title":"Decreased severity of myelin oligodendrocyte glycoprotein peptide 33\u201335-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene","volume":"29","author":"Spahn","year":"1999","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.jns.2013.03.002_bb1025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"3","author":"Sutton","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jns.2013.03.002_bb1030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2010.08.013","article-title":"Gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism","volume":"33","author":"Petermann","year":"2010","journal-title":"Immunity"},{"issue":"Pt 5","key":"10.1016\/j.jns.2013.03.002_bb1035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/brain\/awh453","article-title":"Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis","volume":"128","author":"Ishizu","year":"2005","journal-title":"Brain"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T17:53:38Z","timestamp":1688147618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":207,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0022510X13001081"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.03.002","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}